PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.86%
Revenue growth at 50-75% of META's 12.29%. Martin Whitman would worry about competitiveness or product relevance.
6.53%
Gross profit growth at 50-75% of META's 12.33%. Martin Whitman would question if cost structure or brand is lagging.
-18.24%
Negative EBIT growth while META is at 10.27%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
2.17%
Operating income growth under 50% of META's 16.44%. Michael Burry would be concerned about deeper cost or sales issues.
-18.37%
Negative net income growth while META stands at 10.17%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-17.96%
Negative EPS growth while META is at 10.47%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-17.79%
Negative diluted EPS growth while META is at 11.04%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.50%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.76%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
5.00%
Dividend growth above 1.5x META's 0.21%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-23.24%
Negative OCF growth while META is at 6.39%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-72.03%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
513.13%
10Y revenue/share CAGR under 50% of META's 1223.16%. Michael Burry would suspect a lasting competitive disadvantage.
183.22%
5Y revenue/share CAGR similar to META's 190.49%. Walter Schloss might see both companies benefiting from the same mid-term trends.
50.32%
3Y revenue/share CAGR at 50-75% of META's 77.04%. Martin Whitman would question if the firm lags behind competitor innovations.
347.75%
10Y OCF/share CAGR under 50% of META's 1430.34%. Michael Burry would worry about a persistent underperformance in cash creation.
123.05%
Below 50% of META's 653.02%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
55.19%
3Y OCF/share CAGR under 50% of META's 125.05%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
708.47%
Below 50% of META's 2770.56%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
355.76%
5Y net income/share CAGR 1.25-1.5x META's 304.58%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
91.41%
Below 50% of META's 194.47%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
265.94%
10Y equity/share CAGR at 50-75% of META's 456.53%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
96.90%
5Y equity/share CAGR is in line with META's 101.78%. Walter Schloss would see parallel mid-term profitability and retention policies.
54.35%
3Y equity/share CAGR at 75-90% of META's 66.56%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.94%
AR growth well above META's 14.10%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
5.61%
Similar asset growth to META's 5.19%. Walter Schloss finds parallel expansions or investment rates.
5.64%
Similar to META's 5.80%. Walter Schloss finds parallel capital usage or profit distribution strategies.
50.90%
Debt growth far above META's 0.08%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
1.86%
R&D dropping or stable vs. META's 6.52%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
26.76%
SG&A growth well above META's 12.01%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.